U.S. market Closed. Opens in 22 hours 47 minutes

STSA | Satsuma Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/A
Operating Expenses59.22M51.17M48.33M28.88M7.51M4.95M
Selling, General & Admin15.13M13.53M12.06M4.68M1.08M754.00K
Research & Development44.09M37.63M36.27M24.20M6.43M4.19M
Other Operating Expenses11.73MN/AN/A-1.00KN/AN/A
Operating Income-70.95M-51.17M-48.33M-28.88M-7.51M-4.95M
Other Expenses / Income892.00K-6.00K765.00K706.00K169.00K-225.00K
Before Tax Income-70.06M-51.17M-47.56M-28.18M-7.35M-5.17M
Income Tax Expenses-892.00K92.00K111.00K340.00K259.00KN/A
Net Income-69.16M-51.26M-47.67M-28.52M-7.35M-5.17M
Interest Expenses13.00K163.00K350.00K482.00K90.00K15.00K
Basic Shares Outstanding32.02M29.17M17.41M5.86M3.94M6.80M
Diluted Shares Outstanding32.02M29.17M17.41M5.86M3.94M6.80M
EBITDA-58.31M-50.62M-47.21M-27.69M-7.20M-5.15M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-70.04M-51.01M-47.21M-27.69M-7.00M-5.16M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙